115 related articles for article (PubMed ID: 34643165)
1. The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
Paltta J; Heikkilä HK; Pirilä L; Eklund KK; Huhtakangas J; Isomäki P; Kaipiainen-Seppänen O; Kristiansson K; Havulinna AS; Sokka-Isler T; Palomäki A;
Scand J Rheumatol; 2023 Jan; 52(1):1-9. PubMed ID: 34643165
[TBL] [Abstract][Full Text] [Related]
2. Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available.
Curtis JR; Xie F; Zhou H; Salchert D; Yun H
Arthritis Res Ther; 2020 Oct; 22(1):242. PubMed ID: 33059732
[TBL] [Abstract][Full Text] [Related]
3. The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia.
Almutairi K; Inderjeeth C; Preen DB; Keen H; Rogers K; Nossent J
Rheumatol Int; 2021 Apr; 41(4):741-750. PubMed ID: 33620516
[TBL] [Abstract][Full Text] [Related]
4. Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry.
Linauskas A; Overvad K; Johansen MB; Stengaard-Pedersen K; de Thurah A
Clin Epidemiol; 2018; 10():1709-1720. PubMed ID: 30538575
[TBL] [Abstract][Full Text] [Related]
5. Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study.
Ng B; Aslam F; Petersen NJ; Yu HJ; Suarez-Almazor ME
Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1490-6. PubMed ID: 22623324
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
7. Trends in treatment strategies and the usage of different disease-modifying anti-rheumatic drugs in early rheumatoid arthritis in Finland. Results from a nationwide register in 2000-2007.
Rantalaiho V; Kautiainen H; Virta L; Korpela M; Möttönen T; Puolakka K
Scand J Rheumatol; 2011 Jan; 40(1):16-21. PubMed ID: 20726683
[TBL] [Abstract][Full Text] [Related]
8. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.
Äyräväinen L; Leirisalo-Repo M; Kuuliala A; Ahola K; Koivuniemi R; Meurman JH; Heikkinen AM
BMJ Open; 2017 Jan; 7(1):e011916. PubMed ID: 28143836
[TBL] [Abstract][Full Text] [Related]
9. Validation of rheumatoid arthritis diagnoses in health care utilization data.
Kim SY; Servi A; Polinski JM; Mogun H; Weinblatt ME; Katz JN; Solomon DH
Arthritis Res Ther; 2011 Feb; 13(1):R32. PubMed ID: 21345216
[TBL] [Abstract][Full Text] [Related]
10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative.
Walitt B; Mackey R; Kuller L; Deane KD; Robinson W; Holers VM; Chang YF; Moreland L
Am J Epidemiol; 2013 May; 177(9):887-93. PubMed ID: 23492764
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
13. Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women's Health Study.
Formica MK; McAlindon TE; Lash TL; Demissie S; Rosenberg L
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):235-41. PubMed ID: 20191523
[TBL] [Abstract][Full Text] [Related]
14. ACPA Antibodies Titer at the Time of Rheumatoid Arthritis Diagnosis Is Not Associated with Disease Severity.
Shpatz R; Braun-Moscovici Y; Balbir-Gurman A
Isr Med Assoc J; 2021 Oct; 23(10):646-650. PubMed ID: 34672447
[TBL] [Abstract][Full Text] [Related]
15. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
[TBL] [Abstract][Full Text] [Related]
16. Decline in work disability caused by early rheumatoid arthritis: results from a nationwide Finnish register, 2000-8.
Rantalaiho VM; Kautiainen H; Järvenpää S; Virta L; Pohjolainen T; Korpela M; Möttönen T; Puolakka K
Ann Rheum Dis; 2013 May; 72(5):672-7. PubMed ID: 22679306
[TBL] [Abstract][Full Text] [Related]
17. Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis.
Rannio T; Asikainen J; Kokko A; Hannonen P; Sokka T
J Rheumatol; 2016 Apr; 43(4):699-706. PubMed ID: 26879355
[TBL] [Abstract][Full Text] [Related]
18. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity.
Coffey CM; Crowson CS; Myasoedova E; Matteson EL; Davis JM
Mayo Clin Proc; 2019 Nov; 94(11):2241-2248. PubMed ID: 31619364
[TBL] [Abstract][Full Text] [Related]
19. Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
Molander V; Bower H; Askling J
Scand J Rheumatol; 2023 Mar; 52(2):111-117. PubMed ID: 35023437
[TBL] [Abstract][Full Text] [Related]
20. The validity of systemic sclerosis diagnoses in two university hospitals in Finland.
Paltta J; Kortelainen S; Käyrä M; Pirilä L; Huhtakangas J; Palomäki A
Scand J Rheumatol; 2023 Jan; 52(1):84-87. PubMed ID: 35442148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
